Levin, Adeera;
Ahmed, Sofia B;
Carrero, Juan Jesus;
Foster, Bethany;
Francis, Anna;
Hall, Rasheeda K;
Herrington, Will G;
Hill, Guy;
Inker, Lesley A;
Kazancıoğlu, Rümeyza;
Lamb, Edmund;
Lin, Peter;
Madero, Magdalena;
McIntyre, Natasha;
Morrow, Kelly;
Roberts, Glenda;
Sabanayagam, Dharshana;
Schaeffner, Elke;
Shlipak, Michael;
Shroff, Rukshana;
Tangri, Navdeep;
Thanachayanont, Teerawat;
Ulasi, Ifeoma;
Wong, Germaine;
Yang, Chih-Wei;
Zhang, Luxia;
Robinson, Karen A;
Wilson, Lisa;
Wilson, Renee F;
Kasiske, Bertram L;
Cheung, Michael;
Earley, Amy;
Stevens, Paul E.
Improving Global Outcomes (KDIGO) Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD) updates the KDIGO 2012 guideline and has been developed with patient partners, clinicians, and researchers around the world, using robust methodology. This update, based on a su...
Renal Insufficiency, Chronic/drug therapy,
Renal Insufficiency, Chronic/diagnosis,
Glomerular Filtration Rate,
Creatinine/analysis,
Serum Albumin/analysis,
Glycemic Control,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Sodium-Glucose Transporter 2 Inhibitors/therapeutic use,
Anemia/therapy
The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...
The VA and DoD Evidence-Based Practice Work Group (EBPWG) was established and
first chartered in 2004, with a mission to advise the VA/DoD Health Executive
Committee “on the use of clinical and epidemiological evidence to improve the health of
the population . . .” across the Veterans Health Administ...
Ballarín Castán, José Aurelio;
García López, Fernando;
Ibeas López, José;
Juárez Vela, Raúl;
Ortega Marlasca, Manuel María;
Pequeño Saco, Sandra;
Pérez Contreras, Francisco Javier;
Pérez Maraver, Manuel;
Rigau Comas, David;
Ruiz Hidalgo, Domingo;
anabria Uribe, Andrea Juliana;
Saracho Rotaeche, Ramón.
Objetivos: Esta GPC sobre Enfermedad Renal Crónica (ERC) responde a preguntas clínicas concernientes a su detección precoz, derivación a atención especializada y manejo, tanto mediante tratamiento farmacológico como con medidas higiénico dietéticas, estilos de vida e intervenciones educativas. As...
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/therapy,
Ultrasonography/methods,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Antihypertensive Agents/therapeutic use,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
GRADE Approach,
Life Style,
Diet, Sodium-Restricted,
Diet, Protein-Restricted,
Angiotensin Receptor Antagonists/therapeutic use
Bover Freire, Ramón;
Calderón Montero, Alberto;
Castellanos Rodríguez, Ángel;
Castillo Martín, Juan Ignacio;
Castro Fernández, Antonio;
Colet, Josep Comín;
Delgado Silveira, Eva;
Gamarra Ortiz, Javier;
Gil Martínez, Paloma;
Novell, Montserrat Inglés;
Jurado López, José Alfonso;
Llorens Soriano, Pere;
Manito Lorite, Nicolás;
Mansilla Domínguez, José Miguel;
Manzano Espinosa, Luis;
Martínez Sanz, Henar.
El objetivo general de la Guía de Práctica Clínica es proporcionar a los agentes encargados de la asistencia y cuidados de este tipo de pacientes, una herramienta que les permita tomar las mejores decisiones sobre algunos de los problemas que ocasionan su atención y que no han sido resueltos. Esta Gu...
Heart Failure/therapy,
Angiotensin Receptor Antagonists/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Adrenergic beta-Antagonists/therapeutic use,
Valsartan/therapeutic use,
Defibrillators, Implantable,
Exercise Therapy/methods,
Diet, Healthy/methods,
GRADE Approach
Kantor, PF;
Lougheed, J;
Dancea, A;
McGillion, M;
Barbosa, N;
Chan, C;
Dillenburg, R;
Atallah, J;
Buchholz, H;
Chant-Gambacort, C;
Conway, J;
Gardin, L;
George, K;
Greenway, S;
Human, DG;
Jeewa, A;
Price, JF;
Ross, RD;
Roche, SL;
Ryerson, L;
Soni, R;
Wilson, J;
Wong, K.
Pediatric heart failure (HF) is an important cause of morbidity and mortality in childhood. This article presents guidelines for the recognition, diagnosis, and early medical management of HF in infancy, childhood, and adolescence. The guidelines are intended to assist practitioners in office-based or em...
Angiotensin II Type 1 Receptor Blockers/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors,
Biomarkers/blood,
Cardiotonic Agents,
Catecholamines/therapeutic use,
Diuretics,
Vasodilator Agents,
Vasopressins,
Heart Defects, Congenital,
Death, Sudden, Cardiac/etiology,
Heart Failure,
Myocarditis,
Echocardiography,
Electrocardiography, Ambulatory,
Algorithms,
Heart Defects, Congenital/diagnosis,
Heart Defects, Congenital/therapy,
Myocardium/pathology,
Death, Sudden, Cardiac/prevention & control
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/drug therapy,
Disease Progression,
Triage,
Angiotensin Receptor Antagonists/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Antihypertensive Agents/therapeutic use,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
Hypolipidemic Agents/therapeutic use,
Gemfibrozil/therapeutic use,
Asymptomatic Diseases,
Drug Therapy, Combination,
GRADE Approach
